Clinical Reference Laboratory Market
Clinical Reference Laboratory Market Analysis by Standalone, Clinical-based, and Hospital-based for Clinical Trials and Laboratory Medicines from 2023 to 2033
Analysis of Clinical Reference Laboratory Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Clinical Reference Laboratory Market Outlook (2023 to 2033)
The global clinical reference laboratory market is valued at US$ 234.5 billion in 2023 and is projected to reach a size of US$ 412 billion by the end of 2033, expanding at a CAGR of 5.8% from 2023 to 2033.
Clinical laboratories identify and quantify various chemicals, which can reveal abnormal metabolic processes, infectious and non-infectious disorders, and inflammatory conditions based on changes in biomolecule levels. Effective medical diagnostic procedures and public health rely on the timely and precise diagnosis of severe illnesses and their proper treatment. To detect illnesses and monitor routine health conditions, the utilization of laboratory centrifuges is increasing significantly.
The healthcare industry is expected to witness an increase in the utilization of medical samples, leading to high demand for clinical laboratory services worldwide. Advancements in areas such as hematology, neo-natal screening, serology, and immune histochemistry have created new avenues for market expansion.
- In March 2022, Mindray launched its latest hematology analyzers, the BC-700 Series, designed for small-to-midsize laboratories. These analyzers offer complete blood count (CBC) and erythrocyte sedimentation rate (ESR) testing capabilities.
Pathology services have emerged as a pillar of development for the medical sector. Inferences made from human clinical reference laboratories have helped establish several therapy paths. The field of molecular biology encompasses a wide range of research areas that require constant testing and experimentation. The demand for clinical trials in this field is therefore growing.
Due to a shortage of financing and decreasing reimbursement coverage, hospital finances are quickly becoming constrained. The decreasing cost of laboratory expenses in hospitals is a significant factor driving the outsourcing of laboratory services.
The clinical reference laboratory services sector has grown due to the smooth integration of biochemical research findings into the industry. Standalone labs are capable of efficiently handling large volumes of advanced clinical diagnostic services and delivering superior outcomes at lower costs, resulting in economies of scale for service providers. The market is also expected to benefit from new players entering the standalone clinical lab market, contributing to its expansion.
To meet diagnostic demands, clinical laboratory tests employ a variety of methodologies and technological frameworks. The most widely used technologies in laboratory information management systems include ELISA, chromatography, immunochemistry, spectroscopy, and molecular biology. To determine the concentration of medicines and their metabolites, bioanalytical services are a crucial tool in drug discovery and development.
- For instance, LabCorp expanded its bioanalytical footprint in Asia Pacific in November 2021 by opening a bioanalytical laboratory in Singapore.
Report Attributes |
Details |
|
Market Size in 2022 |
US$ 221.64 Billion |
|
Estimated Market Value (2023) |
US$ 234.5 Billion |
|
Forecasted Market Value (2033) |
US$ 412 Billion |
|
Global Market Growth Rate (2023 to 2033) |
5.8% CAGR |
|
North America Market Share (2023) |
35% |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why is Demand for Clinical Reference Laboratory Services Growing Worldwide?
“Rising Prevalence of Chronic Disorders Driving Demand for Clinical Trials”
Increasing need for clinical trials is driven by the rising prevalence of chronic diseases worldwide. It is expected that these laboratories offering clinical trials will gain more significance in the projected period due to reduced hospital budgets resulting from declining medical reimbursements.
Value-based outsourcing of hospitals is expected to drive the growth of clinical reference medical laboratories in the years to come. The clinical laboratory services sector is expanding due to several factors, including the increasing prevalence of chronic diseases and the growing demand for early diagnostic testing. It is expected that rapid advancements in sample preparation and data management during the forecast period will drive market growth.
“Increasing Collaborations between Clinical Reference Laboratories and Risk Management Providers”
The growth of the clinical reference laboratory market is expected to be boosted by the increasing collaborations between reference laboratories and risk management providers in the projected period. Local vendors pose a significant threat to global vendors in terms of customer acquisition. To address these challenges, established companies are focusing on building relationships with organizations such as health plan providers, integrated delivery networks (IDN), and risk-bearing institutions.
Reference laboratories can retain a steady clientele, speed up expansion, and attain operational efficiencies due to these agreements. By leveraging cutting-edge IT systems and offering effective diagnostic insights, these partnerships enable the unrestrained exchange of knowledge to strengthen the healthcare system.
What Hindrances are Encountered by Clinical Reference Laboratory Service Providers?
“Stringent Regulations Governing Clinical Diagnostic Testing Limiting Demand for Laboratory Testing Services”
Stringent regulations governing laboratory testing are expected to in turn restrict demand for these services. Vendors providing laboratory testing services may be impacted by the complex and constantly changing global laws and regulations.
Frequent changes in the law hinder vendors' capacity to run their firms rapidly in a cutthroat marketplace. Reference tests play a critical role in clinical diagnostic testing technology, as inaccurate or unreliable results can have severe and even fatal implications for patients' health. Regulatory bodies worldwide have thus implemented stringent rules and guidelines to ensure the accuracy and reliability of these tests.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How Can New Market Players Penetrate This Highly Competitive Space?
“New Market Entrants Should Focus on Low-cost Digital Therapy Solutions”
New entrants are offering low-cost testing and therapy solutions to gain a competitive edge.
- PathAI is a start-up that uses artificial intelligence and machine learning to improve the accuracy and speed of pathology diagnoses. The company's platform analyzes digital pathology images and provides insights to pathologists to help them make more informed decisions.
- One recent development from PathAI is the company's acquisition of a digital pathology company called Artificial Intelligence Technology Solutions (AITechS). The acquisition was announced in March 2022 and is expected to strengthen PathAI's position as a leader in the digital pathology market.
Country-wise Insights
Why is the United States a Lucrative Market for Clinical Reference Laboratory Service Companies?
“Strong Presence of Well-established Clinical Laboratory Testing Service Companies”
Several major companies operate in the United States and their continued growth is expected to significantly drive the expansion of the market during the forecast period. The United States is projected to play a crucial role in capturing a substantial share of the global clinical reference laboratory market compared to other countries.
Rising incidence of health problems in the country, favorable regulatory environment, and a well-developed healthcare system are key drivers for the high demand for clinical reference laboratory services in the country.
- In August 2022, LabCorp, a leading global life sciences company, announced the completion of its acquisition of the outreach laboratory operation and certain related assets from RWJBarnabas Health, an academic healthcare system in New Jersey.
What are the Factors Driving Demand for Clinical Reference Laboratory Services in Germany?
“Rising Awareness Regarding Preventive Health Screening in Germany Boosting Demand for Clinical Laboratory Testing Services”
Europe is expected to hold a leading share of the market during the forecast period. Demand for clinical reference laboratory services is anticipated to grow due to various factors. There is an increasing trend towards laboratory outsourcing in Germany. Increasing adoption of the latest technologies by major companies and rising incidence of chronic diseases among the expanding elderly population are also driving demand for these services.
Government programs aimed at raising awareness of preventive screening, increasing support from public and private entities for research on the development of clinical laboratory tests, and rising adoption of genome-based laboratory testing are also contributing to the growth of this market.
Why is the Number of Clinical Laboratories Increasing in India and China?
“Technological Advancements in Genome-based Diagnostics Driving Demand for Clinical Laboratory Testing Services”
Demand for clinical laboratory services in the Asia Pacific region is expected to grow significantly during the forecast period, owing to increased efforts to strengthen the health infrastructure in this region. This demand will also be driven by advancements in the fields of oncology, genome-based testing, and cytogenetics.
Rising healthcare costs, an increase in hospitals and clinical diagnostic labs in China and India, as well as an expanding body of research on clinical laboratory testing methods in China, are contributing to the growth of the market in these countries.
- Roche Diagnostics' Indian division launched the Cobas 100% integrated solutions analyzer in September 2021, which is a sophisticated device suitable for various hospitals and laboratories operating in the country.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Why is the Preference for Hospital-based Testing Increasing Worldwide?
“Increasing Number of Patients with Complex Medical Conditions”
The hospital-based segment is expected to remain a significant contributor to the market throughout the forecast period. Hospitals are the major end users of clinical laboratory services and are increasingly adopting these services. As more hospitals integrate laboratories into their facilities, the hospital-based segment is expected to occupy a leading share of the market.
Increasing adoption of hospital-based testing can be attributed to hospitals' awareness campaigns and the high turnover of patients with serious and complex medical conditions. This is mainly due to the large number of patients seeking treatment for complex and serious medical conditions, which require more expensive testing and a faster turnaround time.
Why Will Clinical Trials Always Be in High Demand?
“Increasing Incidence of Cancer and Heart Diseases Necessitating Detailed Molecular Diagnostics & Testing”
The success of a biochemical research project relies on the integrity upheld by scientists and laboratory professionals. With the increasing prevalence of serious medical conditions such as cancer and heart failure, there is a growing need for molecular diagnostics and testing.
The clinical reference laboratory services market is expected to experience significant growth in the coming years. The demand for clinical laboratory services is being driven by the need to investigate genetic abnormalities in detail, as well as advancements in the field of cytogenetics. The need for clinical diagnostics is anticipated to increase along with the expanding cancer burden.
- Globocan Statistics 2020 revealed that in 2016, there were 19.3 million new cases of cancer globally across both genders. The same source reported a rapid increase in cancer incidence worldwide. It is projected that by 2040, there will be 30.2 million new cases of cancer among both males and females.
Competitive Landscape
The clinical reference laboratory industry is highly competitive, with both local and international companies vying for customers. Companies in the clinical reference laboratory market are also competing fiercely by offering innovative services, allowing them to establish a significant presence in the industry. Due to their increasing reliance on technology, few new players are expected to enter the market in the future, which will further consolidate the market share of existing players.
- In September 2022, Bionano Genomics Inc. launched Bionano Labs, a new company that integrates Lineagen's former clinical testing services with Bionano's optical genome mapping (OGM) data capabilities.
Clinical Reference Laboratory Industry Research Segmentation
-
By Type :
- Standalone
- Clinical-based
- Hospital-based
-
By Application :
- Clinical Trials
- Laboratory Medicine
-
By Region :
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Type modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Type USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Type launches 5.2.2. Cost of Types 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Type 6.4.2. Revenue By Application 6.4.3. Revenue By Country 6.5. 2022 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected Recovery Quarter 7. Global Market Volume (Units) Analysis 2018 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Volume (Units) Analysis, 2018 to 2022 7.2. Current and Future Market Volume (Units) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033 9.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022 9.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Types & Services, 2018 to 2022 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2023 to 2033 10.3.1. Standalone 10.3.2. Clinical-based 10.3.3. Hospital-based 10.4. Market Attractiveness Analysis By Type 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Application , 2018 to 2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application , 2023 to 2033 11.3.1. Clinical Trials 11.3.2. Laboratory Medicine 11.4. Market Attractiveness Analysis By Application 12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018 to 2022 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Type 13.3.3. By Application 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Type 14.3.3. By Application 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Type 15.3.3. By Application 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Type 16.3.3. By Application 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Type 17.3.3. By Application 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Type 18.3.3. By Application 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Type 19.3.3. By Application 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Market Analysis 20.2.1. By Type 20.2.2. By Application 20.3. Canada Market Analysis 20.3.1. By Type 20.3.2. By Application 20.4. Mexico Market Analysis 20.4.1. By Type 20.4.2. By Application 20.5. Brazil Market Analysis 20.5.1. By Type 20.5.2. By Application 20.6. U.K. Market Analysis 20.6.1. By Type 20.6.2. By Application 20.7. Germany Market Analysis 20.7.1. By Type 20.7.2. By Application 20.8. France Market Analysis 20.8.1. By Type 20.8.2. By Application 20.9. Italy Market Analysis 20.9.1. By Type 20.9.2. By Application 20.10. Spain Market Analysis 20.10.1. By Type 20.10.2. By Application 20.11. BENELUX Market Analysis 20.11.1. By Type 20.11.2. By Application 20.12. Russia Market Analysis 20.12.1. By Type 20.12.2. By Application 20.13. China Market Analysis 20.13.1. By Type 20.13.2. By Application 20.14. Japan Market Analysis 20.14.1. By Type 20.14.2. By Application 20.15. South Korea Market Analysis 20.15.1. By Type 20.15.2. By Application 20.16. India Market Analysis 20.16.1. By Type 20.16.2. By Application 20.17. ASEAN Market Analysis 20.17.1. By Type 20.17.2. By Application 20.18. Australia Market Analysis 20.18.1. By Type 20.18.2. By Application 20.19. New Zealand Market Analysis 20.19.1. By Type 20.19.2. By Application 20.20. GCC Countries Market Analysis 20.20.1. By Type 20.20.2. By Application 20.21. Turkey Market Analysis 20.21.1. By Type 20.21.2. By Application 20.22. South Africa Market Analysis 20.22.1. By Type 20.22.2. By Application 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Type foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. OPKO Health Inc. 22.3.1.1. Overview 22.3.1.2. Type Portfolio 22.3.1.3. Profitability by Market Segments (Type/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Quest Diagnostics Incorporated 22.3.2.1. Overview 22.3.2.2. Type Portfolio 22.3.2.3. Profitability by Market Segments (Type/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. Myriad Genetics 22.3.3.1. Overview 22.3.3.2. Type Portfolio 22.3.3.3. Profitability by Market Segments (Type/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. LabCorp 22.3.4.1. Overview 22.3.4.2. Type Portfolio 22.3.4.3. Profitability by Market Segments (Type/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. NeoGenomics 22.3.5.1. Overview 22.3.5.2. Type Portfolio 22.3.5.3. Profitability by Market Segments (Type/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. Unilabs 22.3.6.1. Overview 22.3.6.2. Type Portfolio 22.3.6.3. Profitability by Market Segments (Type/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. Sonic HealthCare Limited 22.3.7.1. Overview 22.3.7.2. Type Portfolio 22.3.7.3. Profitability by Market Segments (Type/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. KingMed Diagnostics 22.3.8.1. Overview 22.3.8.2. Type Portfolio 22.3.8.3. Profitability by Market Segments (Type/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. SYNAB International GmbH 22.3.9.1. Overview 22.3.9.2. Type Portfolio 22.3.9.3. Profitability by Market Segments (Type/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. ARUP Laboratories 22.3.10.1. Overview 22.3.10.2. Type Portfolio 22.3.10.3. Profitability by Market Segments (Type/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018 to 2033, By Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Application
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Application
Table 08: Latin America Market Value (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Application
Table 11: Europe Market Value (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Application
Table 14: South Asia Market Value (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Application
Table 17: East Asia Market Value (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Application
Table 20: Oceania Market Value (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Application
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2033, By Application
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018 to 2022
Figure 02: Global Market Volume Forecast (in 000' Units), 2023 to 2033
Figure 03: Pricing Analysis (US$) Per Type, By Region, 2022
Figure 04: Pricing Analysis (US$) Per Type, By Region, 2022
Figure 05: Global Market Value Analysis (US$ Mn), 2018 to 2022
Figure 06: Global Market Value Forecast (US$ Mn), 2023 to 2033
Figure 07: Global Market Absolute $ Opportunity, 2023 to 2033
Figure 08: Global Market Share Analysis (%), By Type, 2023 to 2033
Figure 09: Global Market Y-o-Y Analysis (%), By Type, 2023 to 2033
Figure 10: Global Market Attractiveness Analysis by Type, 2023 to 2033
Figure 11: Global Market Share Analysis (%), By Application, 2023 to 2033
Figure 12: Global Market Y-o-Y Analysis (%), By Application, 2023 to 2033
Figure 13: Global Market Attractiveness Analysis by Application, 2023 to 2033
Figure 14: Global Market Share Analysis (%), By Region, 2023 to 2033
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2023 to 2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 17: North America Market Value Share, By Type, 2023 (E)
Figure 18: North America Market Value Share, By Application, 2023 (E)
Figure 19: North America Market Value Share, By Country, 2023 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018 to 2022
Figure 21: North America Market Value Forecast (US$ Mn), 2023 to 2033
Figure 22: North America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 23: North America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 24: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 25: Latin America Market Value Share, By Type, 2023 (E)
Figure 26: Latin America Market Value Share, By Application, 2023 (E)
Figure 27: Latin America Market Value Share, By Country, 2023 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018 to 2022
Figure 29: Latin America Market Value Forecast (US$ Mn), 2023 to 2033
Figure 30: Latin America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 31: Latin America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 32: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 33: Europe Market Value Share, By Type, 2023 (E)
Figure 34: Europe Market Value Share, By Application, 2023 (E)
Figure 35: Europe Market Value Share, By Country, 2023 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018 to 2022
Figure 37: Europe Market Value Forecast (US$ Mn), 2023 to 2033
Figure 38: Europe Market Attractiveness Analysis by Type, 2023 to 2033
Figure 39: Europe Market Attractiveness Analysis by Application, 2023 to 2033
Figure 40: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 41: South Asia Market Value Share, By Type, 2023 (E)
Figure 42: South Asia Market Value Share, By Application, 2023 (E)
Figure 43: South Asia Market Value Share, By Country, 2023 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018 to 2022
Figure 45: South Asia Market Value Forecast (US$ Mn), 2023 to 2033
Figure 46: South Asia Market Attractiveness Analysis by Type, 2023 to 2033
Figure 47: South Asia Market Attractiveness Analysis by Application, 2023 to 2033
Figure 48: South Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 49: East Asia Market Value Share, By Type, 2023 (E)
Figure 50: East Asia Market Value Share, By Application, 2023 (E)
Figure 51: East Asia Market Value Share, By Country, 2023 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018 to 2022
Figure 53: East Asia Market Value Forecast (US$ Mn), 2023 to 2033
Figure 54: East Asia Market Attractiveness Analysis by Type, 2023 to 2033
Figure 55: East Asia Market Attractiveness Analysis by Application, 2023 to 2033
Figure 56: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 57: Oceania Market Value Share, By Type, 2023 (E)
Figure 58: Oceania Market Value Share, By Application, 2023 (E)
Figure 59: Oceania Market Value Share, By Country, 2023 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018 to 2022
Figure 61: Oceania Market Value Forecast (US$ Mn), 2023 to 2033
Figure 62: Oceania Market Attractiveness Analysis by Type, 2023 to 2033
Figure 63: Oceania Market Attractiveness Analysis by Application, 2023 to 2033
Figure 64: Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 65: Middle East and Africa Market Value Share, By Type, 2023 (E)
Figure 66: Middle East and Africa Market Value Share, By Application, 2023 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2023 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018 to 2022
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2023 to 2033
Figure 70: Middle East and Africa Market Attractiveness Analysis by Type, 2023 to 2033
Figure 71: Middle East and Africa Market Attractiveness Analysis by Application, 2023 to 2033
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 73: UNITED STATES Market Value Analysis (US$ Mn), 2023 & 2033
Figure 74: UNITED STATES Market Value Share, By Type, 2023 (E)
Figure 75: UNITED STATES Market Value Share, By Application, 2023 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2023 & 2033
Figure 77: Canada Market Value Share, By Type, 2023 (E)
Figure 78: Canada Market Value Share, By Application, 2023 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2023 & 2033
Figure 80: Mexico Market Value Share, By Type, 2023 (E)
Figure 81: Mexico Market Value Share, By Application, 2023 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2023 & 2033
Figure 83: Brazil Market Value Share, By Type, 2023 (E)
Figure 84: Brazil Market Value Share, By Application, 2023 (E)
Figure 85: UNITED KINGDOM Market Value Analysis (US$ Mn), 2023 & 2033
Figure 86: UNITED KINGDOM Market Value Share, By Type, 2023 (E)
Figure 87: UNITED KINGDOM Market Value Share, By Application, 2023 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2023 & 2033
Figure 89: Germany Market Value Share, By Type, 2023 (E)
Figure 90: Germany Market Value Share, By Application, 2023 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2023 & 2033
Figure 92: France Market Value Share, By Type, 2023 (E)
Figure 93: France Market Value Share, By Application, 2023 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2023 & 2033
Figure 95: Italy Market Value Share, By Type, 2023 (E)
Figure 96: Italy Market Value Share, By Application, 2023 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2023 & 2033
Figure 98: Spain Market Value Share, By Type, 2023 (E)
Figure 99: Spain Market Value Share, By Application, 2023 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2023 & 2033
Figure 101: Russia Market Value Share, By Type, 2023 (E)
Figure 102: Russia Market Value Share, By Application, 2023 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2023 & 2033
Figure 104: China Market Value Share, By Type, 2023 (E)
Figure 105: China Market Value Share, By Application, 2023 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2023 & 2033
Figure 107: Japan Market Value Share, By Type, 2023 (E)
Figure 108: Japan Market Value Share, By Application, 2023 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2023 & 2033
Figure 110: South Korea Market Value Share, By Type, 2023 (E)
Figure 111: South Korea Market Value Share, By Application, 2023 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2023 & 2033
Figure 113: India Market Value Share, By Type, 2023 (E)
Figure 114: India Market Value Share, By Application, 2023 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2023 & 2033
Figure 116: ASEAN Market Value Share, By Type, 2023 (E)
Figure 117: ASEAN Market Value Share, By Application, 2023 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2023 & 2033
Figure 119: Australia Market Value Share, By Type, 2023 (E)
Figure 120: Australia Market Value Share, By Application, 2023 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2023 & 2033
Figure 122: New Zealand Market Value Share, By Type, 2023 (E)
Figure 123: New Zealand Market Value Share, By Application, 2023 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2023 & 2033
Figure 125: GCC Countries Market Value Share, By Type, 2023 (E)
Figure 126: GCC Countries Market Value Share, By Application, 2023 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2023 & 2033
Figure 128: Turkey Market Value Share, By Type, 2023 (E)
Figure 129: Turkey Market Value Share, By Application, 2023 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2023 & 2033
Figure 131: South Africa Market Value Share, By Type, 2023 (E)
Figure 132: South Africa Market Value Share, By Application, 2023 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current sales value of clinical reference laboratory services?
The global clinical reference laboratory market stands at US$ 234.5 billion in 2023.
Which region accounts for a leading share of the global market?
North America accounts for 35% share of the market as of 2023.
What is the demand outlook for clinical reference laboratory services?
Demand for clinical reference laboratory services is expected to rise at 5.8% CAGR through 2033.
What is the projected sales value of clinical reference laboratory services for 2033?
Revenue from clinical reference laboratory services is anticipated to reach US$ 412 billion by 2033.
Who are the leading providers of clinical reference laboratory services?
NeoGenomics, LabCorp, and Unilabs are leading providers of clinical reference laboratory services.
Clinical Reference Laboratory Market